Collagenase Clostridium histolyticum in the treatment of Peyronie’s disease: patient selection and perspectives

The safety and efficacy of the use of collagenase Clostridium histolyticum (CCH) for the treatment of Peyronie’s disease has been confirmed over the past several years. However, identification of the ideal patient population for use of this treatment is not well established. Multiple studies have at...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuhlmann, Paige K, DeLay, Kenneth J, Anaissie, James, Hellstrom, Wayne JG, Yafi, Faysal A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338950/
https://www.ncbi.nlm.nih.gov/pubmed/28280315
http://dx.doi.org/10.2147/PPA.S113507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338950/
https://www.ncbi.nlm.nih.gov/pubmed/28280315
http://dx.doi.org/10.2147/PPA.S113507

Ejemplares similares